Oppenheimer Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
|
|||||
|
2025
Q1 | $1.55M | Buy |
|
|||||
|
2024
Q4 | $1.9M | Buy |
|
|||||
|
2024
Q3 | $1.59M | Sell |
|
|||||
|
2024
Q2 | $2.09M | Buy |
|
|||||
|
2024
Q1 | $1.85M | Sell |
|
|||||
|
2023
Q4 | $2.04M | Sell |
|
|||||
|
2023
Q3 | $1.79M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Sell |
|
|||||
|
2023
Q1 | $2.65M | Sell |
|
|||||
|
2022
Q4 | $3.16M | Sell |
|
|||||
|
2022
Q3 | $3.21M | Sell |
|
|||||
|
2022
Q2 | $3.29M | Sell |
|
|||||
|
2022
Q1 | $3.25M | Buy |
|
|||||
|
2021
Q4 | $2.25M | Sell |
|
|||||
|
2021
Q3 | $2.76M | Buy |
|
|||||
|
2021
Q2 | $2.77M | Buy |
|
|||||
|
2021
Q1 | $2.7M | Buy |
|
|||||
|
2020
Q4 | $2.42M | Sell |
|
|||||
|
2020
Q3 | $2.49M | Buy |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|
|||||
|
2020
Q1 | $774K | Buy |
|
|||||
|
2019
Q4 | $812K | Buy |
|
|||||
|
2019
Q3 | $674K | Buy |
|
|||||
|
2019
Q2 | $614K | Sell |
|
|||||
|
2019
Q1 | $659K | Buy |
|
|||||
|
2018
Q4 | $484K | Buy |
|